Substance
ROVELIZUMAB
Global reference: every product and company linked to this substance.
- cas: 339086-79-2
- ncit: C152264
- unii: XLB16RJ01B
HU-23F2G · HU23F2G · LEUKARREST · rovelizumab [INN] · ROVELIZUMAB [USAN]
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.